Official UK procurement notice
NextSeq2000 Sequencing System · UK public procurement notice
Authority: Western Health & Social Care Trust (Central government)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionThe Western Health and Social Care Trust intend to enter into an agreement with Illumina for an Illumina NextSeq 2000 platform under regulation 32(2)(b).
CPV: Biomedical equipment
The lotProcurement structure
single lot · no lot value publishedLot #1Illumina NextSeq2000 Sequencing systemAwarded
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 29 Sept 2022, 10:28 BST
- Last source update
- 4 Nov 2022, 11:16 GMT
- Authority reference
Reference Number: DAC10826- FTS notice number
2022/S 000-031196- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-037144Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
The Western Health and Social Care Trust are relying on regulation 32(2)(b), competition is absent for technical reasons. Illumina is the sole supplier of this specific high throughput sequencing technology/ platform. Illumina sequencing technology, sequencing by synthesis (SBS), is a widely adopted next-generation sequencing (NGS) technology worldwide. Illumina sequencing instruments and reagents support massively parallel, high-throughput sequencing using a proprietary method that detects single bases as they are incorporated into growing DNA strands. Nextseq2000 provides higher sensitivity to detect low-frequency variants, faster turnaround time for high sample volumes, comprehensive genomic coverage, lower limit of detection, higher capacity with sample multiplexing, ability to sequence hundreds to thousands of genes or gene regions simultaneously.
Publisher note: On September 29, 2022, a VEAT was published (Notice reference 2022/S 000-027286), and no challenges were received within the ten-day standstill period. The initial VEAT was only for the purchase of the equipment, but the Contract Award Notice includes subsequent maintenance, which will be paid for by CTRIC rather than the Western Health and Social Care Trust, thus the disparity in values.
Notice history
1 event · 2 releases on Find a Tender- Buyer details updated4 Nov 2022, 11:16 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Illumina Cambridge Ltd | £275,017 † | — | Awarded |
| Illumina Cambridge LtdNextSeq 2000 | £545,098 † | — | Awarded |
Contracts
Contract 027286-2022-1 · Illumina Cambridge Ltd
- Signed
- 29 Sept 2022
- Value
- £275,017
- Status
- active
NextSeq 2000 · Illumina Cambridge Ltd
- Signed
- 29 Sept 2022
- Value
- £545,098
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- Western Health and Social Care TrustContracting authorityBody governed by public lawHealth
Bidders & participating suppliers
1 commercial party on the notice- Illumina Cambridge LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.